Cargando…

Urine lipoarabinomannan for rapid tuberculosis diagnosis in HIV-infected adult outpatients in Khayelitsha

BACKGROUND: Decreasing tuberculosis (TB) mortality is constrained by diagnostic and treatment delays. The World Health Organization (WHO) recently actively recommended the point-of-care Alere Determine Lipoarabinomannan Ag assay (AlereLAM) to assist in the diagnosis of tuberculosis in specific HIV-i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sossen, Bianca, Ryan, Amanda, Bielawski, Joanna, Greyling, Riana, Matthews, Gillian, Hurribunce-James, Sheetal, Goliath, René, Caldwell, Judy, Meintjes, Graeme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AOSIS 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111664/ https://www.ncbi.nlm.nih.gov/pubmed/34007476 http://dx.doi.org/10.4102/sajhivmed.v22i1.1226

Ejemplares similares

Alere Determine-tuberculosis lipoarabinomannan positivity in disseminated non-tuberculous mycobacteria: An illustrative case series
por: Greyling, Riana, et al.
Publicado: (2022)

Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data
por: Broger, Tobias, et al.
Publicado: (2020)

Diagnostic accuracy of 3 urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients
por: Broger, Tobias, et al.
Publicado: (2020)

Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study
por: Broger, Tobias, et al.
Publicado: (2019)

Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study
por: Kaplan, Samantha R., et al.
Publicado: (2017)

Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria
por: Wood, Robin, et al.
Publicado: (2012)

Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study
por: Nicol, Mark P, et al.
Publicado: (2014)

Functional and Activation Profiles of Mucosal-Associated Invariant T Cells in Patients With Tuberculosis and HIV in a High Endemic Setting
por: Balfour, Avuyonke, et al.
Publicado: (2021)

Isolation and purification of lipoarabinomannan from urine of adults with active TB
por: Cantera, J. L., et al.
Publicado: (2023)

Diagnostic Accuracy of Urine Lipoarabinomannan Testing in Early Morning Urine versus Spot Urine for Diagnosis of Tuberculosis among People with HIV
por: Bjerrum, Stephanie, et al.
Publicado: (2022)

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV‐positive adults
por: Shah, Maunank, et al.
Publicado: (2016)

Urine lipoarabinomannan glycan in HIV-negative patients with pulmonary tuberculosis correlates with disease severity
por: Paris, Luisa, et al.
Publicado: (2017)

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV
por: Bjerrum, Stephanie, et al.
Publicado: (2019)

Time to ART Initiation among Patients Treated for Rifampicin-Resistant Tuberculosis in Khayelitsha, South Africa: Impact on Mortality and Treatment Success
por: Daniels, Johnny Flippie, et al.
Publicado: (2015)

Biomarkers for tuberculosis: the case for lipoarabinomannan
por: Correia-Neves, Margarida, et al.
Publicado: (2019)

A systematic review of utility of urine lipoarabinomannan in detecting tuberculosis among HIV-positive tuberculosis suspects
por: Chatla, Chakrapani, et al.
Publicado: (2021)

Prognostic Value of a Quantitative Analysis of Lipoarabinomannan in Urine from Patients with HIV-Associated Tuberculosis
por: Kerkhoff, Andrew D., et al.
Publicado: (2014)

The Diagnostic Accuracy of Urine Lipoarabinomannan Test for Tuberculosis Screening in a South African Correctional Facility
por: Hanifa, Yasmeen, et al.
Publicado: (2015)

“Life continues”: Patient, health care and community care workers perspectives on self-administered treatment for rifampicin-resistant tuberculosis in Khayelitsha, South Africa
por: Mohr, Erika, et al.
Publicado: (2018)

Cost-effectiveness of a Novel Lipoarabinomannan Test for Tuberculosis in Patients With Human Immunodeficiency Virus
por: Reddy, Krishna P, et al.
Publicado: (2020)

Diagnostic accuracy of a novel point-of-care urine lipoarabinomannan assay for the detection of tuberculosis among adult outpatients in Zambia: a prospective cross-sectional study
por: Muyoyeta, Monde, et al.
Publicado: (2021)

Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV
por: Kerkhoff, Andrew D., et al.
Publicado: (2020)

Rapid urine lipoarabinomannan assay as a clinic-based screening test for active tuberculosis at HIV diagnosis
por: Drain, Paul K., et al.
Publicado: (2016)

Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIV
por: Nathavitharana, Ruvandhi R, et al.
Publicado: (2021)

Urine Lipoarabinomannan Testing in Adults With Advanced Human Immunodeficiency Virus in a Trial of Empiric Tuberculosis Therapy
por: Matoga, Mitch M, et al.
Publicado: (2021)

“SILVAMP TB LAM” Rapid Urine Tuberculosis Test Predicts Mortality in Patients Hospitalized With Human Immunodeficiency Virus in South Africa
por: Sossen, Bianca, et al.
Publicado: (2020)

Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review
por: Lawn, Stephen D
Publicado: (2012)

Diagnosing tuberculosis in hospitalized HIV-infected individuals who cannot produce sputum: is urine lipoarabinomannan testing the answer?
por: Sabur, Natasha F., et al.
Publicado: (2017)

Sensitive electrochemiluminescence (ECL) immunoassays for detecting lipoarabinomannan (LAM) and ESAT-6 in urine and serum from tuberculosis patients
por: Broger, Tobias, et al.
Publicado: (2019)

Improved Alere Determine Lipoarabinomannan Antigen Detection Test for the Diagnosis of Human and Bovine Tuberculosis by Manipulating Urine and Milk
por: García, Juan Ignacio, et al.
Publicado: (2019)

Cost-effectiveness of diagnostic algorithms including lateral-flow urine lipoarabinomannan for HIV-positive patients with symptoms of tuberculosis
por: Yakhelef, Nadia, et al.
Publicado: (2020)

Value of urine-based lipoarabinomannan (LAM) antigen tests for diagnosing tuberculosis in children: systematic review and meta-analysis
por: Seid, Getachew, et al.
Publicado: (2022)

A Sensitive Urinary Lipoarabinomannan Test for Tuberculosis
por: Hamasur, Beston, et al.
Publicado: (2015)

Lipoarabinomannan in Active and Passive Protection Against Tuberculosis
por: Correia-Neves, Margarida, et al.
Publicado: (2019)

Combining urine lipoarabinomannan with antibody detection as a simple non-sputum-based screening method for HIV-associated tuberculosis
por: Younis, Hiba, et al.
Publicado: (2019)

Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis
por: Spies, Ruan, et al.
Publicado: (2022)

Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine
por: De, Prithwiraj, et al.
Publicado: (2015)

Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes
por: Magni, Ruben, et al.
Publicado: (2020)

Correction: Potential value of urine lateral-flow lipoarabinomannan (LAM) test for diagnosing tuberculosis among severely acute malnourished children
por: Schramm, Birgit, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3vc316o3edeeon8uu98jef7vb3